Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol

BACKGROUND: Salvage external beam radiotherapy (sEBRT) for patients with a biochemical recurrence (BCR) after radical prostatectomy provides a 5-year biochemical progression-free survival up to 60%. Multiple studies have shown that dose escalation to the primary prostate tumour improves treatment ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Staal, F. H. E., Janssen, J., Brouwer, C. L., Langendijk, J. A., Ng Wei Siang, K., Schuit, E., de Jong, I. J., Verzijlbergen, J. F., Smeenk, R. J., Aluwini, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013125/
https://www.ncbi.nlm.nih.gov/pubmed/35428210
http://dx.doi.org/10.1186/s12885-022-09493-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013125/
https://www.ncbi.nlm.nih.gov/pubmed/35428210
http://dx.doi.org/10.1186/s12885-022-09493-5

Ejemplares similares